194 related articles for article (PubMed ID: 21295154)
1. Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics.
Li CY; Wang EQ; Cheng Y; Bao JK
Int J Biochem Cell Biol; 2011 May; 43(5):701-4. PubMed ID: 21295154
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-suppressing and autophagy-promoting effects of calpain on oridonin-induced L929 cell death.
Cheng Y; Qiu F; Huang J; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2008 Jul; 475(2):148-55. PubMed ID: 18468506
[TBL] [Abstract][Full Text] [Related]
3. Oridonin: targeting programmed cell death pathways as an anti-tumour agent.
Liu Z; Ouyang L; Peng H; Zhang WZ
Cell Prolif; 2012 Dec; 45(6):499-507. PubMed ID: 23106297
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.
Kang N; Zhang JH; Qiu F; Tashiro S; Onodera S; Ikejima T
Cancer Lett; 2010 Aug; 294(2):147-58. PubMed ID: 20202741
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin.
Tian W; Chen SY
Chin J Integr Med; 2013 Apr; 19(4):315-20. PubMed ID: 23546635
[TBL] [Abstract][Full Text] [Related]
6. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells.
Wang H; Ye Y; Pan SY; Zhu GY; Li YW; Fong DW; Yu ZL
Phytomedicine; 2011 Jan; 18(2-3):163-9. PubMed ID: 20724128
[TBL] [Abstract][Full Text] [Related]
8. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
9. [Autophagy of prostate cancer PC-3 cells under the induction of oridonin].
Ye LH; Chen YL; Tao SX; Jiang XQ; Li WJ; Qian WL; He JS
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(42):2984-8. PubMed ID: 21211311
[TBL] [Abstract][Full Text] [Related]
10. Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells.
Zang L; Xu Q; Ye Y; Li X; Liu Y; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2012 Feb; 518(1):31-41. PubMed ID: 22155150
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of downregulation of apoptosis by autophagy induced by oridonin in HeLa cells].
Cui Q; Tashiro S; Onodera S; Ikejima T
Yao Xue Xue Bao; 2007 Jan; 42(1):35-9. PubMed ID: 17520804
[TBL] [Abstract][Full Text] [Related]
12. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Guo ZM; Tashiro S; Onodera S; Ikejima T
FEBS J; 2009 Mar; 276(5):1291-306. PubMed ID: 19187231
[TBL] [Abstract][Full Text] [Related]
13. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
Hsieh TC; Wijeratne EK; Liang JY; Gunatilaka AL; Wu JM
Biochem Biophys Res Commun; 2005 Nov; 337(1):224-31. PubMed ID: 16176802
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.
Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J
Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570
[TBL] [Abstract][Full Text] [Related]
15. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
[TBL] [Abstract][Full Text] [Related]
16. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J
Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204
[TBL] [Abstract][Full Text] [Related]
17. Polygonatum cyrtonema lectin, a potential antineoplastic drug targeting programmed cell death pathways.
Wang SY; Yu QJ; Bao JK; Liu B
Biochem Biophys Res Commun; 2011 Mar; 406(4):497-500. PubMed ID: 21329660
[TBL] [Abstract][Full Text] [Related]
18. Targeting apoptotic and autophagic pathways for cancer therapeutics.
Liu JJ; Lin M; Yu JY; Liu B; Bao JK
Cancer Lett; 2011 Jan; 300(2):105-14. PubMed ID: 21036469
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyl radical (·OH) played a pivotal role in oridonin-induced apoptosis and autophagy in human epidermoid carcinoma A431 cells.
Yu Y; Fan SM; Song JK; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2012; 35(12):2148-59. PubMed ID: 23207767
[TBL] [Abstract][Full Text] [Related]
20. Induction of G(2)/M phase arrest and apoptosis by oridonin in human laryngeal carcinoma cells.
Kang N; Zhang JH; Qiu F; Chen S; Tashiro S; Onodera S; Ikejima T
J Nat Prod; 2010 Jun; 73(6):1058-63. PubMed ID: 20496901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
